The observed increase in the abundance of CCR1, CCR4 and/or CCR5+CD8+ T cells may reflect an RT-induced T-cell response directed against NPC tissue, after which these T cells efflux from the tumor into the blood of responding patients. The gene discussed is CD8A; the disease is neoplasm.